The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 6th 2024
The rheumatology month in review emphasizes new trends in medication use and novel technologies' potential for managing fibromyalgia.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Medical Marijuana: Smoke & Mirrors?
February 2nd 2010When our home state of New Jersey became the 14th state in the nation to legalize medical marijuana, OBTN decided to take a closer look at the herbal remedy. With help from oncologists on our advisory board, we sought to filter through the smoke and examine the realities of medical marijuana.
Osteoarthritis treatment update: Are NSAIDs still in the picture?
February 1st 2010Although NSAIDs are the most effective treatment for persons who experience the pain of osteoarthritis (OA), the risk of adverse effects with NSAIDs may outweigh the benefits in many older patients. The GI risk is well known; increased attention has been paid recently to the cardiovascular risk. The goals of OA management are pain reduction and improvement or preservation of mobility. A multidisciplinary approach to treatment is recommended.
Biomarker Could Help Doctors Tailor Treatment for Rheumatoid Arthritis
January 29th 2010TNF antagonists are not highly effective in 30 to 50 percent of patients, but investigators have discovered that patients with higher baseline levels of type I interferon beta were more likely to respond to therapy.
Do age and bone density alone predict fracture risk as well as FRAX?
January 29th 2010A simple model based on age and bone mineral density (BMD) alone may predict 10-year risk of hip, major osteoporotic, and any clinical fracture in older women as well as more complex fracture risk assessment tool (FRAX) models with BMD.
Use adult RA assessment tools for juvenile idiopathic arthritis?
January 29th 2010Continuous measures of disease activity used for assessment of adult rheumatoid arthritis may be valid measures in children with polyarticular-course juvenile idiopathic arthritis (JIA). The scores may be valid in larger cohorts of children with polyarticular-course JIA that include children with early JIA and with varying degrees of disease severity.
Autoantibodies put patients on watch list for cardiovascular disease
January 29th 2010Both systemic inflammation and immune dysregulation, including autoantibody production, may occur even in the absence of autoimmune rheumatologic diseases, such as rheumatoid arthritis and systemic lupus erythematosus.
Lupus an independent risk factor for coronary artery disease
January 28th 2010Women with systemic lupus erythematosus (SLE) are at increased risk for coronary artery disease (CAD) and mortality. The dominant risk factors are SLE itself, age, and high total triglyceride levels rather than the traditional Framingham risk factors.
New Ways to Use Social Networking Sites
USA Today has published an interesting opinion piece by Kevin Pho, MD, encouraging physicians to embrace social networking tools as a way to interact with patients. For me, the comments on the article were as interesting as the article itself.
Apple's iPad an Impressive Product in Need of Tweaking for Healthcare Success
January 28th 2010Apple's iPad is sleek, innovative, and should change the landscape of the tablet computer market going forward. But for all the things they got right, Apple has a few things to learn if it wants to become the the healthcare industry's tablet leader.
Psoriasis more severe, with more psychological effects, in minorities
January 28th 2010Psychological effects resulting from psoriasis and psoriatic arthritis (PsA) are more likely to occur in African Americans, Asians, and Latinos than in whites, according to a recent National Psoriasis Foundation (NPF) survey report. In addition, very severe disease is more common among members of these groups.
New glenohumeral osteoarthritis guidelines recommend arthroplasty
January 27th 2010Total shoulder arthroplasty (TSA) is preferred over hemiarthroplasty in the treatment of patients who have glenohumeral osteoarthritis (GHOA) in the strongest of 16 recommendations in a new evidence-based clinical practice guideline developed by the American Academy of Orthopaedic Surgeons (AAOS). The AAOS guideline is designed to help physicians improve treatment of patients with shoulder pain by applying the best current evidence in making clinical decisions about GHOA.
Public Citizen Files a Petition to Remove Fibromyalgia Drug from the Market
January 26th 2010Last week, the non-profit, consumer advocacy group known as Public Citizen filed a petition to the FDA on the removal of Savella, a selective serotonin and norepinephrine dual reuptake inhibitor used to treat fibromyalgia, from the market.
ACL injury risk greater on the other side
January 26th 2010The risk of sustaining a contralateral anterior cruciate ligament (ACL) injury is greater than the risk of sustaining a first-time ACL injury, according to investigators in the department of orthopedics at Lund University and Lund University Hospital, Lund, Sweden. The most important risk factor for sustaining a contralateral ACL injury is return to a high activity level after a unilateral ACL injury.
Doctors Without Borders Plane with Lifesaving Medical Supplies Diverted Again from Landing in Haiti
January 19th 2010A Doctors Without Borders/Médecins Sans Frontières cargo plane carrying 12 tons of medical equipment, including drugs, surgical supplies and two dialysis machines, was turned away three times from Port-au-Prince airport since Sunday night despite repeated assurances of its ability to land there.